{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029513","form_type":"8-K","ticker":"CODX","cik":"0001692415","company_name":"Co-Diagnostics, Inc.","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.162495+00:00","generated_at":"2026-05-16T12:00:17.138271+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Co-Diagnostics files 1-for-30 reverse stock split to regain Nasdaq minimum bid price compliance","bullets":["Reverse stock split ratio set at 1-for-30; effective January 2, 2026 at 12:01 a.m. ET.","Approximately 2,095,031 shares outstanding post-split; new CUSIP 189763204; ticker CODX unchanged.","Fractional shares rounded up to next whole share; no fractional shares issued.","Split intended to enable compliance with Nasdaq $1.00 minimum bid price listing requirement.","Board approved ratio on Dec 29, 2025; stockholders authorized up to 1-for-30 at Dec 5 special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029513","json":"https://secwatch.observer/filing/0001493152-25-029513.json","markdown":"https://secwatch.observer/filing/0001493152-25-029513.md","text":"https://secwatch.observer/filing/0001493152-25-029513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1692415/000149315225029513/0001493152-25-029513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1692415/000149315225029513/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:00:17.138271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}